Nanoparticles: Small and mighty

International Journal of Dermatology

Volumn 50, Issue 3, 2011, Pages 247-254

  Wiesenthal, Alison ^a   Hunter, Lindsey ^b   Wang, Shuguang ^c   Wickliffe, Jeffrey ^c   Wilkerson, Michael ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; DERMATOLOGICAL AGENT; HYDROQUINONE; PODOPHYLLOTOXIN; PREDNICARBATE; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; RETINOID; SOLID LIPID NANOPARTICLE; SUNSCREEN; TETRAMETHYLAMMONIUM HYDROXIDE; TITANIUM DIOXIDE; ZINC OXIDE;

ACNE VULGARIS; ATOPIC DERMATITIS; CONDYLOMA ACUMINATUM; DRUG FORMULATION; HUMAN; HYPERPIGMENTATION; NANOTECHNOLOGY; NONHUMAN; REVIEW; SKIN ABSORPTION; SKIN DEFECT; STRATUM CORNEUM; ULTRAVIOLET A RADIATION; VIRUS INFECTION; WART VIRUS;

DERMATOLOGIC AGENTS; DERMATOLOGY; HUMANS; NANOPARTICLES; SKIN DISEASES;

EID: 79951924708     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04815.x     Document Type: Review

References (48)

1. National Nanotechnology Initiative. (accessed February 2nd, 2010).
2. Nanotechnology: Big Things from a Tiny World. (accessed September 9th, 2009).
3. Bawa R. Patents and nanomedicine. Nanomedicine 2007; 2: 351-374.
4. Kahan DM, Slovic P, Braman D, et al. Nanotechnology risk perceptions: the influence of affect and values. In: Woodrow Wilson International Center for Scholars, 2009.
5. Wilson Center and the Pew Charitable Trusts. Nanotech-enabled Consumer Products Top the 1, 000 Mark. Wilson Center and the Pew Charitable Trusts, 2009.
6. Nohynek GJ, Lademann J, Ribaud C, et al. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 2007; 37: 251-277.
7. Roco MC. Environmentally responsible development of nanotechnology. Environ Sci Technol 2005; 39: 106A-112A.
8. Greenwood NN, Earnshaw A. Chemistry of the Elements. Oxford: Pergamon, 1984, 1117-1119.
9. Datye AK, Riegel G, Bolton JR, et al. Microstructural characterization of a fumed titanium dioxide photocatalyst. J Solid State Chem 1995; 115: 236-239.
10. Liang S-S, Makamba H, Huang S-Y, et al. Nano-titanium dioxide composites for the enrichment of phosphopeptides. J Chromatogr A 2006; 1116: 38-45.
11. Nakano K, Egashira K, Masuda S, et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv 2009; 2(4): 277-283.
12. Rolland A. Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline. Int J Pharm 1989; 54: 113-121.
13. Tseng C, Su W, Yen K, et al. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009; 30: 3476-3485.
14. Liu G, Men P, Kudo W, et al. Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer's disease. Neurosci Lett 2009; 455: 187-190.
15. Turosa E, Shima JY, Wang Y, et al. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett 2007; 17: 53-56.
16. Katsambas AD. Why and when the treatment of acne fails. What to do. Dermatology 1998; 196: 158-161.
17. Webster GF. Topical tretinoin in acne therapy. J Am Acad Dermatol 1998; 39: S38-S44.
18. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49: S1-S38.
19. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366: 170-184.
20. Wolff K, Johnson RA. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 6th edn. Part III-Diseases due to microbial agents; Section 30: Sexually transmitted infections. New York: McGraw-Hill, 2009. pp. 896-941.
21. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006; 110: 296-306.
22. Sato K, Matsumoto D, Iizuka F, et al. A clinical trial of topical bleaching treatment with nanoscale tretinoin particles and hydroquinone for hyperpigmented skin lesions. Dermatol Surg 2007; 33: 937-944.
23. Yoshimura K, Tsukamoto K, Okazaki M, et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci 2001; 27(Suppl. 1): S68-S75.
24. Gatti R, Gioia MG, Cavrini V. Analysis and stability study of retinoids in pharmaceuticals by LC with fluorescence detection. J Pharm Biomed Anal 2000; 23: 147-159.
25. Alam M, Kundu RV, Bhatia AC, et al. Cosmetic Dermatology for Skin of Color. New York: McGraw-Hill, 2008.
26. Schäfer-Korting M, Mehnert W, Korting H. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007; 59: 427-443.
27. Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 2005; 137: 319-325.
28. Wolff K, Johnson RA. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 6th edn. Part I-Disorders presenting in the skin and mucous membranes: Section 2: Eczema/Dermatitis. 2009. New York: McGraw-Hill, 2009. pp. 20-52.
29. Maia CS, Mehnert W, Schaller M, et al. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002; 10: 489-495.
30. Kimbrell G. Nanotechnology and nanomaterials in consumer products: regulatory challenges and necessary amendments. FDA Public Meeting on Nanotechnology, 2006. .
31. Rastogia R, Ananda S, Koula V. Flexible polymerosomes-an alternative vehicle for topical delivery. Colloids Surf B 2009; 72: 161-166.
32. 2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 2009; 191: 1-8.
33. Sharma V, Shukla RK, Saxena N, et al. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol Lett 2009; 185: 211-218.
34. Dussert AS, Gooris E. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci 1997; 19: 119-129.
35. 2 and its UV absorption for sunscreen cosmetic. Surf Interface Anal 2006; 38: 473-477.
36. 2 particles. Cancer Res 1992; 52(8): 2346-2348.
37. 2-UVA treatment. Toxicol In Vitro 2002; 16: 629-635.
38. Consumer-Union. 2007 Sunscreens: some are short on protection. Consum Rep 2007; 72: 6.
39. Barker P, Branch A. The interaction of modern sunscreen formulations with surface coatings. Prog Org Coat 2008; 62: 313-320.
40. Barry B. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101-114.
41. Newman MD, Stotland M, Ellis JI. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J Am Acad Dermatol 2009; 61: 685-692.
42. Nohynek GJ, Dufour EK, Roberts MS. Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol 2008; 21(3): 136-149.
43. Baroli B, Ennas MG, Loffredo F, et al. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007; 127: 1701-1712.
44. Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev 2001; 50: 205-227.
45. Warheit D, Sayes C, Reed K, et al. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther 2008; 120: 35-42.
46. Sieber M, Pietsch H, Walter J, et al. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Invest Radiol 2008; 43: 65-75.
47. Boyd A, Zic J, Abraham J. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007; 56: 27-30.
48. Gordon LG, Scuffham PA, van der Pols JC, et al. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings. J Invest Dermatol 2009; 129: 12.